Flubeta 5 Tablet SR is a combination medication containing Propranolol 40mg and Flunarizine 5mg, designed to manage various cardiovascular and neurological conditions. Propranolol, a non-selective beta-blocker, works by blocking beta-adrenergic receptors, thereby reducing heart rate, blood pressure, and myocardial oxygen demand, making it effective in treating hypertension, angina, and certain arrhythmias. Flunarizine, a calcium channel blocker with antihistaminic properties, helps prevent migraine attacks and manage vertigo by inhibiting calcium influx into cells, stabilizing vascular tone, and reducing neuronal excitability. The sustained-release formulation ensures a gradual and prolonged release of the active ingredients, promoting consistent therapeutic effects and improving patient compliance by reducing dosing frequency. Flubeta 5 Tablet SR is commonly prescribed for patients experiencing migraine prophylaxis alongside cardiovascular conditions such as hypertension or tachycardia. It should be taken under medical supervision, considering potential contraindications like asthma, bradycardia, or severe hypotension. Common side effects may include fatigue, dizziness, gastrointestinal discomfort, or cold extremities. Patients are advised to avoid abrupt discontinuation to prevent rebound symptoms. Overall, Flubeta 5 Tablet SR offers a synergistic approach to managing coexisting cardiovascular and neurological disorders, enhancing quality of life through effective symptom control.